Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification

Clinical trial NCT04880811 · UNKNOWN

Trial details

NCT number: NCT04880811
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2021-07-01
Primary completion: 2022-10-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.